Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial
Authors:
- for Japanese Study Group of Renal Disease in ChildrenFCfor Japanese Study Group of Renal Disease in Children
- Kenji IshikuraKIKenji Ishikura
- Koichi NakanishiKNKoichi Nakanishi
- 3 October 2014
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 30 (3) , 459-468
Abstract
To investigate the long-term outcome in children with frequently relapsing nephrotic syndrome (FRNS) we conducted a follow-up of a previous randomized controlled trial (RCT) 10 years after the initiation of the treatment protocol. We previously conducted an RCT on the efficacy of cyclosporine for treating children with FRNS. After 2 years of treatment, a recommended a management protocol of steroids, and immunosuppressants was provided. Valid information was available for 46 of the 56 patients (82.1 %) enrolled in the original RCT. The median follow-up period was 10.3 years from the start of protocol treatment with cyclosporine. At last follow-up (mean age 18.7 years), only ten patients (21.7 %) showed disease-free remission (no relapse for at least 2 years). In contrast, 23 (50.0 %) continued to relapse frequently or were on immunosuppressants, eight patients (17.4 %) had infrequent relapses without immunosuppressants. Adverse effects attributable to treatment included short stature (6 patients), osteoporosis (six patients), obesity (4 patients), cataracts (3 patients) and hypertension (3 patients). No lethal event or renal dysfunction occurred during follow-up. This 10-year follow-up study shows that most children with FRNS experience relapses after 2 years of cyclosporine treatment, in adolescence and into adulthood. Outcomes in terms of life expectancy and renal function are favorable.Keywords
This publication has 25 references indexed in Scilit:
- Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGOPediatric Nephrology, 2012
- Two-Year Follow-Up of a Prospective Clinical Trial of Cyclosporine for Frequently Relapsing Nephrotic Syndrome in ChildrenClinical Journal of the American Society of Nephrology, 2012
- Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndromeNephrology Dialysis Transplantation, 2011
- Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndromeNephrology Dialysis Transplantation, 2010
- Management of Childhood Onset Nephrotic SyndromePediatrics, 2009
- Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in childrenPediatric Nephrology, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].2006
- Steroid-sensitive nephrotic syndrome: From childhood to adulthoodAmerican Journal of Kidney Diseases, 2003
- Early identification of frequent relapsers among children with minimal change nephrotic syndromeThe Journal of Pediatrics, 1982